Company Filing History:
3 out of 517 
2 out of 2,971 
Years Active: 2018-2021
Title: Mark A Herman: Innovator in Lipid Research
Introduction
Mark A Herman is a notable inventor based in Needham, MA (US). He has made significant contributions to the field of lipid research, particularly in developing compounds that enhance insulin sensitivity. With a total of 3 patents to his name, his work has implications for various metabolic disorders.
Latest Patents
One of Mark A Herman's latest patents focuses on lipids that increase insulin sensitivity and methods of using them. This invention introduces fatty acyl hydroxy fatty acid (FAHFA), a novel class of estolide-related molecules. The patent outlines diagnostic and treatment methods for a range of disorders, including diabetes-related conditions, Metabolic Syndrome, polycystic ovarian syndrome, cancer, and inflammatory disorders. Additionally, it includes methods for screening other compounds that may be beneficial in treating these disorders and modulating FAHFA levels and signaling.
Career Highlights
Throughout his career, Mark A Herman has worked with prestigious institutions such as Beth Israel Deaconess Medical Center and Harvard College. His research has been instrumental in advancing our understanding of lipid metabolism and its effects on health.
Collaborations
Mark has collaborated with esteemed colleagues, including Barbara B Kahn and Alan Saghatelian, further enhancing the impact of his research in the scientific community.
Conclusion
Mark A Herman's innovative work in lipid research continues to pave the way for new treatments for metabolic disorders. His contributions are vital in the ongoing quest to improve health outcomes for individuals affected by these conditions.